tenofovir has been researched along with Trichomonas Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, M; Andrew, P; Baepanye, K; Burns, D; Cohen, MS; Corey, L; Donnell, D; Edupuganti, S; Garnett, P; Gomez Lorenzo, MM; Greene, E; Hural, J; Juraska, M; Karg, C; Karuna, S; Kochar, N; Lazarus, E; Ledgerwood, J; Luthuli, N; Marshall, K; Mascola, JR; Mgodi, NM; Miner, MD; Mukwekwerere, PG; Rudnicki, E; Shava, E; Takuva, S; Tindale, I | 1 |
1 trial(s) available for tenofovir and Trichomonas Infections
| Article | Year |
|---|---|
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
Topics: Adolescent; Adult; AIDS Vaccines; Antibodies, Monoclonal; Botswana; Broadly Neutralizing Antibodies; Chlamydia; Chlamydia Infections; Contraception; Double-Blind Method; Female; Gonorrhea; HIV Antibodies; HIV Infections; HIV-1; Humans; Incidence; Kenya; Malawi; Middle Aged; Mozambique; Prevalence; Sexually Transmitted Diseases; South Africa; Syphilis; Tenofovir; Trichomonas; Trichomonas Infections; Young Adult | 2021 |